Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?
Crossref DOI link: https://doi.org/10.1007/s11060-016-2097-x
Published Online: 2016-03-03
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Franceschi, E.
Bartolotti, M.
Paccapelo, A.
Marucci, G.
Agati, R.
Volpin, L.
Danieli, D.
Ghimenton, C.
Gardiman, M. P.
Sturiale, C.
Poggi, R.
Mascarin, M.
Balestrini, D.
Masotto, B.
Brandes, A. A.
Text and Data Mining valid from 2016-03-03